REQUEST A DEMO
Total
USD $0.00
Search more companies

Southern Luzon Drug Corporation (Philippines)

Main Activities: Pharmacies and Drug Stores
Full name: Southern Luzon Drug Corporation Profile Updated: February 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Southern Luzon Drug Corporation is a Philippine pharmaceutical company that operates in both drug manufacturing and drugstore retail segments. With roots dating back to the mid-1990s, the company maintains manufacturing operations in Batangas, where it has developed capabilities in producing a broad range of generic and branded medicines across therapeutic categories such as anti-infectives, pain management, cardiovascular drugs, and other essential pharmaceuticals. Its facilities employ modern production lines and quality-control systems aligned with current good manufacturing practices. In addition to manufacturing, Southern Luzon Drug Corporation operates a network of drugstores and pharmacies, with corporate offices and distribution centered in Quezon City and branches in Southern Luzon and surrounding regions. This integrated model allows the company to supply its own outlets as well as independent pharmacies, hospitals, and institutional customers. Key assets include its manufacturing plant, distribution depots, retail outlets, and long-standing relationships with healthcare professionals and institutional buyers. Strategically, Southern Luzon Drug Corporation positions itself as a regional leader in accessible, quality-assured medicines, focusing on competitive pricing, reliable supply, and expansion of its retail and distribution footprint to better serve communities in and beyond Southern Luzon.

Legal Address
7 Richmond Avenue, Bagumbayan, Quezon City
Quezon City; National Capital Region; Postal Code: 1110

Contact Details: Purchase the Southern Luzon Drug Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Southern Luzon Drug Corporation report to view the information.
Financial Auditors:
Purchase the Southern Luzon Drug Corporation report to view the information.
Incorporation Date:
October 26, 1994
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Other
Purchase this report to view the information.
Other
Purchase this report to view the information.
Other
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Southern Luzon Drug Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
11.7%
Total operating revenue
11.65%
Operating profit (EBIT)
28.87%
EBITDA
28.87%
Net Profit (Loss) for the Period
26.8%
Total assets
-0.27%
Total equity
64.86%
Operating Profit Margin (ROS)
0.23%
Net Profit Margin
0.15%
Return on Equity (ROE)
-123.76%
Debt to Equity Ratio
-549.81%
Quick Ratio
-0.02%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?